Oncolytics Biotech Ownership | Who Owns Oncolytics Biotech?

Oncolytics Biotech Ownership Summary

Oncolytics Biotech is owned by 3.50% institutional investors, 2.05% insiders, and 94.45% retail investors. Marshall wace, llp is the largest institutional shareholder, holding 0.66% of ONCY shares. Invesco NASDAQ Future Gen 200 ETF is the top mutual fund, with 0.09% of its assets in Oncolytics Biotech shares.

ONCY Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Oncolytics Biotech	3.50%	2.05%	94.45%
Sector	Healthcare Stocks	50.50%	12.33%	37.17%
Industry	Biotech Stocks	49.09%	12.06%	38.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Marshall wace, llp	745.35K	0.66%	$708.08K
Sandbox financial partners	400.00K	0.42%	$339.52K
International assets investment management	201.26K	0.18%	$181.28K
Connective capital management	185.71K	0.17%	$176.41K
Goldman sachs group	169.90K	0.15%	$161.39K
Quadrature capital	106.08K	0.12%	$146.38K
Invesco	101.19K	0.09%	$96.13K
Royal bank of canada	57.41K	0.05%	$55.00K
Cibc private wealth group	50.00K	0.05%	$43.70K
Fifth third bancorp	45.53K	0.04%	$43.24K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Connective capital management	185.71K	0.12%	$176.41K
Sandbox financial partners	400.00K	0.10%	$339.52K
Security national bank of sioux city iowa /ia/	33.26K	0.02%	$28.23K
International assets investment management	201.26K	0.01%	$181.28K
Scientech research	18.20K	0.01%	$25.49K
Catalyst funds management pty	31.68K	0.00%	$30.09K
Quadrature capital	106.08K	0.00%	$146.38K
Spc financial	12.50K	0.00%	$17.50K
Valley national advisers	12.00K	0.00%	$11.40K
Badgley phelps wealth managers	40.00K	0.00%	$38.00K

Top Buyers

Holder	Shares	% Assets	Change
Sandbox financial partners	400.00K	0.10%	400.00K
International assets investment management	201.26K	0.01%	201.26K
Connective capital management	185.71K	0.12%	185.71K
Goldman sachs group	169.90K	-	169.90K
Quadrature capital	106.08K	0.00%	106.08K

Top Sellers

Holder	Shares	% Assets	Change
Renaissance	-	-	-715.84K
Seeds investor	-	-	-258.31K
Tocqueville asset management	-	-	-149.00K
Everhart financial group	-	-	-138.16K
Marshall wace, llp	745.35K	0.00%	-114.48K

New Positions

Holder	Shares	% Assets	Change	Value
Sandbox financial partners	400.00K	0.10%	400.00K	$339.52K
International assets investment management	201.26K	0.01%	201.26K	$181.28K
Connective capital management	185.71K	0.12%	185.71K	$176.41K
Goldman sachs group	169.90K	-	169.90K	$161.39K
Quadrature capital	106.08K	0.00%	106.08K	$146.38K

Sold Out

Holder	Change
Russell investments group	-1.00
Ifp advisors	-100.00
Pacifica partners	-100.00
Evolution wealth management	-105.00
Dogwood wealth management	-146.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	76	33.33%	3,933,580	31.27%	3	49.19%	42	35.48%	9	200.00%
Mar 31, 2026	56	-8.20%	2,996,321	7.11%	3	41.00%	30	36.36%	3	-40.00%
Dec 31, 2025	36	-35.71%	1,385,405	-50.88%	1	14.24%	9	-52.63%	2	-71.43%
Sep 30, 2025	30	-43.40%	910,881	-32.37%	1	39.52%	5	-76.19%	2	-60.00%
Jun 30, 2025	55	12.24%	1,492,518	10.47%	1	55.94%	23	9.52%	5	-28.57%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Invesco NASDAQ Future Gen 200 ETF	107.52K	0.09%	-
Fidelity Nasdaq Composite Index	66.94K	0.06%	-
Vifag 2002 SICAV	30.00K	0.04%	-
Victory Extended Market Index	13.51K	0.01%	13.51K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 11, 2026	Parsons James T.	-	Buy	$10.30K
Mar 12, 2026	Kelly Jared	Chief Executive Officer	Buy	$4.85K
Feb 12, 2026	Kelly Jared	Chief Executive Officer	Buy	$24.84K
Feb 11, 2026	Kelly Jared	Chief Executive Officer	Buy	$4.68K
Feb 12, 2026	Look Kirk	Chief Financial Officer	Buy	$10.10K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	14	-

ONCY Ownership FAQ

Who Owns Oncolytics Biotech?

Oncolytics Biotech shareholders are primarily institutional investors at 3.50%, followed by 2.05% insiders and 94.45% retail investors. The average institutional ownership in Oncolytics Biotech's industry, Biotech Stocks , is 49.09%, which Oncolytics Biotech falls below.

Who owns the most shares of Oncolytics Biotech?

Oncolytics Biotech’s largest shareholders are Marshall wace, llp (745.35K shares, 0.66%), Sandbox financial partners (400K shares, 0.42%), and International assets investment management (201.26K shares, 0.18%). Together, they hold 1.26% of Oncolytics Biotech’s total shares outstanding.

Does Blackrock own Oncolytics Biotech?

BlackRock is not among the top 10 institutional shareholders of Oncolytics Biotech.

Who is Oncolytics Biotech’s biggest shareholder by percentage of total assets invested?

Connective capital management is Oncolytics Biotech’s biggest shareholder by percentage of total assets invested, with 0.12% of its assets in 185.71K Oncolytics Biotech shares, valued at 176.41K$.

Who is the top mutual fund holder of Oncolytics Biotech shares?

Invesco NASDAQ Future Gen 200 ETF is the top mutual fund holder of Oncolytics Biotech shares, with 0.09% of its total shares outstanding invested in 107.52K Oncolytics Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools